Patents by Inventor Bruce K. Rubin

Bruce K. Rubin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AEROSOLIZED DAPSONE AS A THERAPY FOR INFLAMMATION OF THE AIRWAY AND ABNORMAL MUCOCILIARY TRANSPORT
    Publication number: 20180243213
    Abstract: Aerosolized dapsone (or alternatively, an aqueous formulation of dapsone) is used to treat airway inflammation, particularly chronic neutrophil-dominated inflammation. Diseases that may be prevented or treated by the methods include chronic obstructive pulmonary diseases (COPDs), asthma, cystic fibrosis, and others.
    Type: Application
    Filed: February 20, 2018
    Publication date: August 30, 2018
    Applicant: VIRGINIA COMMONWEALTH UNIVERSITY
    Inventors: Bruce K. RUBIN, Soichiro KANOH, Tsuyoshi TANABE
  • Aerosolized Dapsone as a Therapy for Inflammation of the Airway and Abnormal Mucociliary Transport
    Publication number: 20150040894
    Abstract: Aerosolized dapsone (or alternatively, an aqueous formulation of dapsone) is used to treat airway inflammation, particularly chronic neutrophil-dominated inflammation. Diseases that may be prevented or treated by the methods include chronic obstructive pulmonary diseases (COPDs), asthma, cystic fibrosis, and others.
    Type: Application
    Filed: October 22, 2014
    Publication date: February 12, 2015
    Applicant: VIRGINIA COMMONWEALTH UNIVERSITY
    Inventors: Bruce K. Rubin, Soichiro Kanoh, Tsuyoshi Tanabe
  • AEROSOLIZED DAPSONE AS A THERAPY FOR INFLAMMATION OF THE AIRWAY AND ABNORMAL MUCOCILIARY TRANSPORT
    Publication number: 20130005822
    Abstract: Aerosolized dapsone (or alternatively, an aqueous formulation of dapsone) is used to treat airway inflammation, particularly chronic neutrophil-dominated inflammation. Diseases that may be prevented or treated by the methods include chronic obstructive pulmonary diseases (COPDs), asthma, cystic fibrosis, and others.
    Type: Application
    Filed: March 8, 2011
    Publication date: January 3, 2013
    Inventors: Bruce K. Rubin, Soichiro Kanoh, Tsuyoshi Tanabe
  • Use of surface active agents to promote mucus clearance
    Patent number: 5925334
    Abstract: This disclosure is of a surfactant mixed with an aerosollizing agent, and deposited by such agent, as a treatment for airway obstruction. It has been extensively tested, and has proved successful. It has been hypothesized that the addition of a hypersmolor drug will help to minimize mucus in the airways.
    Type: Grant
    Filed: August 27, 1997
    Date of Patent: July 20, 1999
    Inventors: Bruce K. Rubin, Michael T Newhouse